Dystrophic dendrites in prefrontal cortical pyramidal cells of dopamine D1 and D2 but not D4 receptor knockout mice

Brain Research

Volumn 1300, Issue , 2009, Pages 58-64

  Wang, Hui Dong ^a   Stanwood, Gregg D ^a,b   Grandy, David K ^c   Deutch, Ariel Y ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Dendritic spine; Dopamine receptor; Golgi impregnation; Parkinson's disease; Pyramidal cell; Schizophrenia

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; BIOCHEMISTRY; CELL DENSITY; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC SPINE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; SPINE; ANALYSIS OF VARIANCE; ANIMAL; CELL SHAPE; CYTOLOGY; DENDRITE; GENETICS; MOUSE MUTANT; SILVER STAINING;

MUS;

ANALYSIS OF VARIANCE; ANIMALS; CELL SHAPE; DENDRITES; MALE; MICE; MICE, KNOCKOUT; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SILVER STAINING;

EID: 73949106578     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.09.008     Document Type: Article

References (43)

1. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., and Lewis D.A. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry 156 (1999) 1580-1589
2. Araki K.Y., Sims J.R., and Bhide P.G. Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development. Brain Res. 1156 (2007) 31-45
3. 3 dopamine receptors in vivo. J. Neurosci. 27 (2007) 881-885
4. 2 receptors in the striatum causes persistent deficits in conditional associative learning. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 16027-16032
5. 5 dopamine receptors in primate brain. J. Neurosci. 15 (1995) 7821-7836
6. Black J.E., Kodish I.M., Grossman A.W., Klintsova A.Y., Orlovskaya D., Vostrikov V., Uranova N., and Greenough W.T. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am. J. Psychiatry 161 (2004) 742-744
7. 5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals. J. Comp. Neurol. 508 (2008) 893-905
8. Broadbelt K., Byne W., and Jones L.B. Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr. Res. 58 (2002) 75-81
9. Carr D.B., and Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20 (2000) 3864-3873
10. 2 dopamine receptor-deficient mice. J. Neurophysiol. 85 (2001) 659-670
11. Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., Wokosin D., Ilijic E., Sun Z., Sampson A.R., Mugnaini E., Deutch A.Y., Sesack S.R., Arbuthnott G.W., and Surmeier D.J. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 9 (2006) 251-259
12. 2 receptors in reversal learning. Neuroscience 162 (2009) 118-127
13. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., Barnes T.R., and Hirsch S.R. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry 65 (1998) 446-453
14. 2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur. J. Neurosci. 7 (1995) 1050-1063
15. Glantz L.A., and Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57 (2000) 65-73
16. 3 receptors. Ann. N.Y. Acad. Sci. 1025 (2004) 110-118
17. 3 receptors have spatial working memory deficits. J. Neurosci. 22 (2002) 5619-5629
18. 1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) 174 (2004) 3-16
19. 1 receptors. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3236-3241
20. 2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49 (2006) 603-615
21. 2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J. Neurosci. 18 (1998) 3470-3479
22. Kolluri N., Sun Z., Sampson A.R., and Lewis D.A. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry 162 (2005) 1200-1202
23. 4 receptor-deficient mice, congenic on the C57BL/6J background, are hypersensitive to amphetamine. Synapse 53 (2004) 131-139
24. 6 receptor gene variations in healthy adults. J. Psychiatry Neurosci. 33 (2008) 47-53
25. 1 receptor binding associated with cognitive training. Science 323 (2009) 800-802
26. 2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 5 (1991) 231-242
27. 2 receptor and coexistence with the calcium-binding protein neuronal calcium sensor-1 in the primate prefrontal cortex. J. Comp. Neurol. 488 (2005) 464-475
28. 4 receptor gene using BAC transgenic mice. Eur. J. Neurosci. 24 (2006) 2429-2438
29. Perez-Costas E., Guidetti P., Melendez-Ferro M., Kelley J.J., and Roberts R.C. Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays. J. Neural Transm. 115 (2008) 745-753
30. Rodriguez J.J., and Pickel V.M. Enhancement of N-methyl-d-aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudate-putamen nucleus after chronic haloperidol administration. Synapse 33 (1999) 289-303
31. 4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90 (1997) 991-1001
32. Schmauss C., Glickstein S.B., Adlersberg M., Hsiung S.C., and Tamir H. A single dose of methamphetamine rescues the blunted dopamine D(1)-receptor activity in the neocortex of D(2)- and D(3)-receptor knockout mice. Ann. N.Y. Acad. Sci. 965 (2002) 21-27
33. Selemon L.D., and Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45 (1999) 17-25
34. Sesack S.R., Carr D.B., Omelchenko N., and Pinto A. Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann. N.Y. Acad. Sci. 1003 (2003) 36-52
35. 1 receptor mutant mice. J. Comp. Neurol. 487 (2005) 270-282
36. Takahashi H., Kato M., Takano H., Arakawa R., Okumura M., Otsuka T., Kodaka F., Hayashi M., Okubo Y., Ito H., and Suhara T. Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functions. J. Neurosci. 28 (2008) 12032-12038
37. Trantham-Davidson H., Kroner S., and Seamans J.K. Dopamine modulation of prefrontal cortex interneurons occurs independently of DARPP-32. Cereb. Cortex 18 (2008) 951-958
38. 2 receptors in rat medial prefrontal cortex. J. Neurosci. 13 (1993) 2551-2564
39. Waddington J.L., O'Tuathaigh C., O'Sullivan G., Tomiyama K., Koshikawa N., and Croke D.T. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. Psychopharmacology (Berl) 181 (2005) 611-638
40. 2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J. Comp. Neurol. 442 (2002) 392-404
41. Wang H.D., and Deutch A.Y. Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment. Neuropsychopharmacology 33 (2008) 1276-1286
42. 2 receptor actions on the functional circuitry of working memory. Science 303 (2004) 853-856
43. 2A and muscarinic receptors. Psychopharmacology (Berl) 141 (1999) 267-278